ERBB2 and neoplasm: Microarray technology to evaluate gene expression in human breast cancer samples allowed researchers to identify gene expression profiles that characterized several genetically distinct tumor subtypes denoted as normal-like, luminal-A, luminal-B, HER2+, and triple-negative/basal-like (30, 31).